China Regenerative Medicine International Limited

HKEX
8158
Stock
Yield per half year: +79.25%
Dividend yield: 0%
Sector: Healthcare

China Regenerative Medicine International Limited

1.0101.0100.8270.8270.6440.6440.4600.4600.2770.2770.0940.094Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
4.54 37.2 -87.79% 17.37 -73.85%
P/S 0.8898 4.03 -77.92%
P/BV 3.2 1.93 65.4%
P/FCF 15.34 -10.12 -251.64%
Ev/Ebitda 41.58 2.91 1330.07%
Ev/S 1.18 7.34 -83.9%
Ev/FCF 6.05 -11 -155.03%
E/P 0.0655 0.0327 100.01%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
10.15 1.46 595.52% -35.25 -128.8%
ROE 95.98 3.98 2314.25%
ROA 11.04 2.89 282.31%
ROIC 0 0 0%
ROS 19.59 10.86 80.37%
ROCE 0 0.1527 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
5.34 0.3827 1294.64% 4.31 +23.92%
Nеt Debt/Ebitda 2.87 -0.2202 -1403.41%
Debt/Ratio 0.3618 0.132 174.07%
Debt/Equity 4.39 0.6875 537.93%
Debt/Net Income 2.77 2.61 6.07%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 4.32 -100% 440.67 -100%
Number of years of dividend growth 2 1.23 62.71%
DSI 0.6667 0.5482 21.61%
Average dividend growth 97.62 -2.77 -3620.24%
Average percentage for 5 years 440.67 4.29 10177.04%
Average percentage for payments 0 34.1 -100%
Difference from average difference in sector -4.32

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-51.11 -94.75 -46.06%
Growth impulse Ebitda in 5 years -40.7 -45.56 -10.67%
Growth impulse Net Income in 5 years -104.39 -111.86 -6.68%
Growth impulse FCF in 5 years -104.44 -138.06 -24.35%
Growth impulse EPS in 5 years -141.2 -139.77 1.02%
IP Score
4.05/10

Similar companies

Zai Lab Limited

JD Health International Inc.

Hangzhou Tigermed Consulting Co., Ltd

WuXi Biologics (Cayman) Inc.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription